Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 9/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.36 |
| ▸ | SLC2A3 | P11169 | 3/20 | 0.36 |
| ▸ | SLC2A4 | P14672 | 3/20 | 0.36 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.35 |
| ▸ | GCK | P35557 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | F10 | P00742 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10140202 | 0.94 | KLKB1 (0.38) | KLKB1SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL11893226 | 0.93 | KLKB1 (0.41) | KLKB1SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL782240 | 0.91 | SLC2A1 (0.38) | KLKB1SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL672741 | 0.90 | PDE4B (0.36) | KLKB1PDE4BF10 | |
| SCHEMBL14360665 | 0.90 | KDM4E (0.37) | KLKB1PDE4BOPRL1 | |
| SCHEMBL11893156 | 0.90 | SLC2A1 (0.37) | KLKB1SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL14470584 | 0.90 | PDE4B (0.36) | KLKB1PDE4BOPRL1 | |
| SCHEMBL960289 | 0.90 | SLC2A1 (0.42) | KLKB1SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL31059991 | 0.90 | SLC2A1 (0.42) | KLKB1SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL563295 | 0.90 | KCNH2 (0.37) | SLC2A1SLC2A3SLC2A4SLC2A2PDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210378242-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION, LLC (US) | 2021-12-09 | — | — | US | disclosed |
| US-10405548-B2 | Fungicidal compositions | SYNGENTA CROP PROTECTION LLC (US) | 2019-09-10 | — | — | US | disclosed |
| EP-2547665-B1 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2018-07-04 | — | — | EP | disclosed |
| US-9949482-B2 | Fungicidal compositions | SYNGENTA CROP PROTECTION, LLC (US) | 2018-04-24 | — | — | US | disclosed |
| US-9771365-B2 | Spiroheterocyclic N-oxypiperidines as pesticides | SYNGENTA PARTICIPATIONS AG (CH) | 2017-09-26 | — | — | US | disclosed |
| US-9771365-B2 | Spiroheterocyclic N-oxypiperidines as pesticides | SYNGENTA PARTICIPATIONS AG (CH) | 2017-09-26 | — | — | US | disclosed |
| US-20170071205-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION, LLC (US) | 2017-03-16 | — | — | US | disclosed |
| US-20170027173-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION, LLC (US) | 2017-02-02 | — | — | US | disclosed |
| US-20170027173-A1 | INSECTICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION, LLC (US) | 2017-02-02 | — | — | US | disclosed |
| EP-2723723-B1 | N-OXY PYRAZOLO-TRIAZEPINE-DIONE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-02-01 | — | — | EP | disclosed |
| US-20080182750-A1 | Cyano Anthranilamide Insecticides | SYNGENTA CROP PROTECTION, INC. (US) | 2008-07-31 | — | — | US | disclosed |
| US-20080146552-A1 | Anthranilamide Derivatives as Insecticides | SYNGENTA CROP PROTECTION, INC. | 2008-06-19 | — | — | US | disclosed |
| US-20080146552-A1 | Anthranilamide Derivatives as Insecticides | SYNGENTA CROP PROTECTION, INC. | 2008-06-19 | — | — | US | disclosed |
| US-20070244073-A1 | Pesticidal Mixtures | SYNGENTA CROP PROTECTION, INC. (US) | 2007-10-18 | — | — | US | disclosed |
| US-20070244073-A1 | Pesticidal Mixtures | SYNGENTA CROP PROTECTION, INC. (US) | 2007-10-18 | — | — | US | disclosed |
| WO-2007093402-A1 | PESTICIDES CONTAINING A BICYCLIC BISAMIDE STRUCTURE | SYNGENTA PARTICIPATIONS AG (CH) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007080131-A2 | ANTHRANILAMIDE DERIVATIVES AND THEIR USE FOR THE CONTROL OF INSECTS AND ACARI | SYNGENTA PARTICIPATIONS AG (CH) | 2007-07-19 | — | — | WO | disclosed |
| WO-2007068356-A1 | INSECTICIDAL COMPOSITIONS WITH IMPROVED EFFECT | BAYER CROPSCIENCE AG (DE) | 2007-06-21 | — | — | WO | disclosed |
| WO-2007020050-A2 | BICYCLIC BISAMIDE DERIVATIVES AND USE THEREOF AS INSECTICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2007-02-22 | — | — | WO | disclosed |
| WO-2007009661-A2 | PESTICIDAL MIXTURES CONTAINING BICYCLIC ANTHRANILAMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2007-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210378242-A1 | FUNGICIDAL COMPOSITIONS | PIK3C3, CYP51A1, CYP1B1 | KLKB1 3263/4885SLC2A1 4040/4885SLC2A3 3742/4885 |
| US-20170027173-A1 | INSECTICIDAL COMPOUNDS | ACHE, AADAC, CASP3 | KLKB1 3945/4885SLC2A1 4777/4885SLC2A3 4496/4885 |
| US-20080146552-A1 | Anthranilamide Derivatives as Insecticides | DDT, ALDH7A1, AADAC | KLKB1 4513/4885SLC2A1 4038/4885SLC2A3 4464/4885 |
| US-20070244073-A1 | Pesticidal Mixtures | ACHE, ATL3, BPHL | KLKB1 4646/4885SLC2A1 4394/4885SLC2A3 4206/4885 |
| US-20080182750-A1 | Cyano Anthranilamide Insecticides | CRY1, CRYAA, ALDH7A1 | KLKB1 4334/4885SLC2A1 3493/4885SLC2A3 4368/4885 |
| US-10405548-B2 | Fungicidal compositions | PIK3C3, CYP51A1, CYP1B1 | KLKB1 3263/4885SLC2A1 4040/4885SLC2A3 3742/4885 |
| US-20170071205-A1 | FUNGICIDAL COMPOSITIONS | PIK3C3, CYP51A1, CYP1B1 | KLKB1 3263/4885SLC2A1 4040/4885SLC2A3 3742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.